(Q46047569)

English

Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation

scientific article published in April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

Andreas Hochhaus

10

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

13

object named as

Ulrike Bacher

1 reference

Europe PubMed Central

19 December 2017

Susanne Schnittger

9

object named as

Susanne Schnittger

1 reference

Europe PubMed Central

19 December 2017

5

object named as

Francis Ayuk

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

author name string

Sunday Ocheni

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Gabriela B Iwanski

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Philippe Schafhausen

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Axel Rolf Zander

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Evgeny Klyuchnikov

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Tatjana Zabelina

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Walter Fiedler

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Tim H Brümmendorf

11

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Nicolaus Kröger

12

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

publication date

1 April 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Leukemia & Lymphoma

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

50

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

551-558

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Complete remission from chronic myelogenous leukemia--blastic crisis caused by reduced intensity stem cell transplantation following partial remission due to imatinib

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Chronic myeloid leukemia: standard treatment options

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Strategies for overcoming imatinib resistance in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Localized lymphoid relapse in the pancreas following allogeneic hematopoietic stem cell transplant for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Isolated extramedullary relapse in the pleural fluid of a patient with acute myeloid leukemia following allogeneic BMT.

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Granulocytic sarcoma: 32 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant.

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

A clinical review of breast involvement in acute leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Isolated cavernous sinus extramedullary relapse of chronic myelogenous leukemia following allogeneic stem cell transplant

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Granulocytic sarcoma as isolated extramedullary relapse after donor lymphocyte infusion in a patient with CML who relapsed after allogeneic bone marrow transplantation: a case report

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Radiologic spectrum of extramedullary relapse of myelogenous leukemia in adults

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report.

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Low concentrations of STI571 in the cerebrospinal fluid: a case report

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors. The Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético)

1 reference

https://api.crossref.org/works/10.1080%2F10428190902755513

21 January 2018

Identifiers

10.1080/10428190902755513

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19373652

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46047569&oldid=2089369274"